NCT05483127

Brief Summary

The primary purpose of this study is to demonstrate noninferiority in the visual acuity at distance when wearing PRECISION1™ for Astigmatism (P1fA) soft contact lenses compared to another commercially available, soft toric contact lens, MyDay® toric (MDT).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
153

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

11 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 29, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 1, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

September 13, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2022

Completed
1 year until next milestone

Results Posted

Study results publicly available

November 2, 2023

Completed
Last Updated

November 2, 2023

Status Verified

October 1, 2023

Enrollment Period

2 months

First QC Date

July 29, 2022

Results QC Date

October 9, 2023

Last Update Submit

October 9, 2023

Conditions

Keywords

Contact lensesVisionEye sight

Outcome Measures

Primary Outcomes (1)

  • Least Squares Means Distance Visual Acuity With Study Lenses at Week 1

    Distance visual acuity (VA) was assessed with study lenses in place. VA was collected for each eye separately using logarithmic of the Minimum Angle of Resolution (logMAR) charts. LogMAR typically ranges from -0.3 (20/10 vision on the Snellen chart) to 1 (20/200 vision). A logMAR acuity of 0.0 corresponds to 20/20 Snellen (normal distance visual acuity), with a negative value denoting better than 20/20 visual acuity.

    Day 8 of each study lens type worn during the corresponding crossover period

Study Arms (2)

P1fA, then MDT

OTHER

Verofilcon A toric soft contact lenses worn first, followed by stenfilcon A toric soft contact lenses, as randomized. Each study lens type will be worn for 8 (-0/+3) days for at least 10 hours per day. Lenses will be removed nightly and disposed of after a single use.

Device: Verofilcon A toric soft contact lensesDevice: Stenfilcon A toric soft contact lenses

MDT, then P1fA

OTHER

Stenfilcon A toric soft contact lenses worn first, followed by verofilcon A toric soft contact lenses, as randomized. Each study lens type will be worn for 8 (-0/+3) days for at least 10 hours per day. Lenses will be removed nightly and disposed of after a single use.

Device: Verofilcon A toric soft contact lensesDevice: Stenfilcon A toric soft contact lenses

Interventions

Soft contact lenses for optical correction of ametropia and astigmatism

Also known as: PRECISION1™ for Astigmatism, P1fA
MDT, then P1fAP1fA, then MDT

Soft contact lenses for optical correction of ametropia and astigmatism

Also known as: MyDay® toric soft contact lenses, MDT
MDT, then P1fAP1fA, then MDT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Successful wearers of toric soft contact lenses in both eyes with at least 3 months wearing experience, with a minimum wearing time of 5 days per week and 10 hours per day.
  • Able to wear contact lenses within a range of sphere \& cylinder power and axes.
  • Willing to NOT use rewetting/lubricating drops at any time during the study.

You may not qualify if:

  • Current or previous P1fA and MDT habitual lens wearers.
  • Monovision and multifocal lens wearers.
  • Participation of the subject in a clinical trial within the previous 30 days or currently enrolled in any clinical trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (11)

Kurata Eyecare Center

Los Angeles, California, 90012, United States

Location

Sabal Eye Care

Longwood, Florida, 32779, United States

Location

Drs. Giedd, P.A.

Maitland, Florida, 32751, United States

Location

Vision Health Institute

Orlando, Florida, 32803, United States

Location

Franklin Park Eye Center

Franklin Park, Illinois, 60131, United States

Location

Kannarr Eye Care

Pittsburg, Kansas, 66762, United States

Location

Heart of America Eye Care, P.A.

Shawnee Mission, Kansas, 66204, United States

Location

Wesley Optometric Consulting

Medina, Minnesota, 55340, United States

Location

ProCare Vision Center

Granville, Ohio, 43023, United States

Location

West Bay Eye Associates

Warwick, Rhode Island, 02888, United States

Location

Optometry Group, PLLC

Memphis, Tennessee, 38111, United States

Location

MeSH Terms

Conditions

AstigmatismRefractive ErrorsMyopia

Condition Hierarchy (Ancestors)

Eye Diseases

Results Point of Contact

Title
Associate Director, CRD Vision Care
Organization
Alcon Research, LLC

Study Officials

  • Sr. Clinical Trial Lead, Vision Care

    Alcon Research, LLC

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 29, 2022

First Posted

August 1, 2022

Study Start

September 13, 2022

Primary Completion

October 31, 2022

Study Completion

October 31, 2022

Last Updated

November 2, 2023

Results First Posted

November 2, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations